Zweig DiMenna Associates LLC Buys Shares of 110,700 SPDR S&P Biotech ETF $XBI

Zweig DiMenna Associates LLC bought a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 110,700 shares of the exchange traded fund’s stock, valued at approximately $13,498,000. Zweig DiMenna Associates LLC owned approximately 0.17% of SPDR S&P Biotech ETF at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. China Universal Asset Management Co. Ltd. increased its holdings in SPDR S&P Biotech ETF by 868.3% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 4,919 shares of the exchange traded fund’s stock valued at $493,000 after acquiring an additional 4,411 shares in the last quarter. Ashton Thomas Private Wealth LLC purchased a new position in SPDR S&P Biotech ETF during the 3rd quarter valued at about $417,000. Banque Pictet & Cie SA increased its holdings in SPDR S&P Biotech ETF by 24.1% during the 4th quarter. Banque Pictet & Cie SA now owns 64,877 shares of the exchange traded fund’s stock valued at $7,910,000 after acquiring an additional 12,595 shares in the last quarter. Apella Capital LLC purchased a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $490,000. Finally, Mirae Asset Global Investments Co. Ltd. purchased a new position in SPDR S&P Biotech ETF during the 3rd quarter valued at about $1,287,000.

SPDR S&P Biotech ETF Trading Up 0.5%

NYSEARCA:XBI opened at $136.69 on Friday. The firm has a 50-day moving average price of $130.99 and a two-hundred day moving average price of $125.94. SPDR S&P Biotech ETF has a twelve month low of $78.06 and a twelve month high of $139.19. The company has a market capitalization of $8.72 billion, a P/E ratio of 11.47 and a beta of 0.85.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.